aTyr Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting

NEXT STORY
Aeterna Zentaris Continues to Demonstrate Pipeline Expansion – Announces the Initiation of Its Preclinical Program for the Potential Treatment of Primary Hypoparathyroidism
PREV STORY
Acerus Reports Fourth Quarter and Full Year 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®

author_avatar
NASDAQ Market News

BeyondSpring to Host First-Quarter 2018 Financial Results Conference Call on June 21, 2018

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage ...

author_avatar
NASDAQ Market News

Biogen Further Expands Presence in China with Approval of SPINRAZA® (nusinersen), the First and Only Treatment for Spinal Muscular Atrophy

author_avatar
NASDAQ Market News